* Q2 loss narrows from yr-ago qtr
* Q2 revenue falls 15 pct
(In U.S. dollars)
Aug 6 (Reuters) - Angiotech Pharmaceuticals Inc ANP.TO ANPI.O reported a narrower second-quarter loss on Thursday, helped by lower research costs.
The Vancouver, British Columbia-based company posted a net loss of $11.9 million, or 14 cents a share, compared with a net loss of $26.1 million, or 31 cents a share, a year-ago.
Excluding items, the company posted a net loss of 2 cents a share.
Revenue for the company, which makes coating for Boston Scientific Corp’s BSX.N stents, fell 15 percent to $64.6 million.
Research and development expenses fell 63 percent to $6.8 million. (Reporting by Anuradha Ramanathan in Bangalore; Editing by Aradhana Aravindan)